Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 0.45 |
| ▸ | SCN4A | P35499 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | LAP3 | P28838 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7956104 | 1.00 | TAAR1 (0.45) | TAAR1SCN4AHTR2AMAOAPTGS1 | |
| SCHEMBL7956107 | 1.00 | TAAR1 (0.45) | TAAR1SCN4AHTR2AMAOAPTGS1 | |
| SCHEMBL7971274 | 0.82 | TAAR1 (0.42) | TAAR1SCN4AMAOAPTGS1LMNA | |
| SCHEMBL7971270 | 0.82 | TAAR1 (0.42) | TAAR1SCN4AMAOAPTGS1LMNA | |
| SCHEMBL7971268 | 0.82 | TAAR1 (0.42) | TAAR1SCN4AMAOAPTGS1LMNA | |
| Anisole SCHEMBL28429653 | 0.73 | CA4 (0.54) | TAAR1MAOASLC6A2SLC6A4 | |
| SCHEMBL471824 | 0.72 | CA4 (0.43) | TAAR1SCN4AMAOAPTGS1LMNA | |
| SCHEMBL7965736 | 0.72 | SLC1A3 (0.45) | TAAR1MAOASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7965733 | 0.72 | SLC1A3 (0.45) | TAAR1MAOASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7965740 | 0.72 | SLC1A3 (0.45) | TAAR1MAOASLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6274715-B1 | SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY | ABBOTT LABORATORIES | 2001-08-14 | — | — | US | disclosed |
| EP-0961776-A1 | TRICYCLIC ERYTHROMYCIN DERIVATIVES | Abbott Laboratories (US) | 1999-12-08 | — | — | EP | disclosed |
| WO-1998030574-A1 | TRICYCLIC ERYTHROMYCIN DERIVATIVES | ABBOTT LABORATORIES (US) | 1998-07-16 | — | — | WO | disclosed |